Markets have been seeing red continuously. Nifty is down by 2.6% in last five trading sessions. We got rid of two positions from momentum portfolio as they were breaking down. On 23-Sep we added Aarti drugs to our momentum portfolio. Fundamentally the company had decent results. Revenue was up by 2.17% and PAT was remarkably up by 37% YoY. Aarti Drugs has generated 80.68% of revenue from speciality chemicals, 13.87% from pharmaceuticals and and rest from home and personal care chemicals. The company has recently . . .